As of today, effective and safe treatment of bacterial endocarditis remains one of the last unmet medical needs in cardiology. devie medical transforms the treatment of bacterial endocarditis with an evolutionary transcatheter platform for drug delivery. By merging cutting edge medical technology with a proprietary pharmacological concept, we are not only defining the next frontier in an emerging therapeutic area, but pushing the boundaries for cardiovascular interventions.